4.7
31 Ratings with 15 written Reviews
VERIFIED 

Overview based on verified provider data
To Whom It May Concern: I am writing this letter with profound gratitude and the highest possible recommendation for Dr. Marc Smaldone and the team at Fox Chase Cancer Center. This is not simply a recommendation for an excellent surgeon. It is the story of a physician who was willing to take on an extraordinarily difficult case when the possibility of losing my only remaining kidney—and spending the rest of my life on dialysis—had become very real. I will turn 69 years old in one week. Looking back at everything my family and I have faced since 2018, I realize that reaching 69 with my remaining kidney functioning, my independence intact, and another opportunity at life is something I will never take for granted. My journey began in January 2018, when I underwent a right radical nephrectomy for clear cell renal cell carcinoma, staged pT3a. From that day forward, my left kidney became my only kidney. Cancer, unfortunately, was not finished with me. In April 2021, I underwent surgery… for a 2.5 cm small-bowel neuroendocrine tumor, with one of seven lymph nodes positive. Along the way, I also developed significant cardiovascular disease. My medical history came to include coronary artery disease requiring placement of a drug-eluting coronary stent, heart failure with preserved ejection fraction, and paroxysmal atrial fibrillation. These conditions—and the medications necessary to manage them, including blood-thinning and antiplatelet therapy—added another layer of complexity and risk to any major operation. By late 2025, approaching my 69th birthday, I had already faced kidney cancer, the loss of my right kidney, another form of cancer, coronary artery disease, coronary intervention with a stent, atrial fibrillation, and heart failure. Then came another challenge. In December 2025, imaging revealed a new solid mass of approximately 6 cm in my only remaining left kidney. This was not a straightforward kidney tumor. Because of its size, location and relationship to critical structures—including finger-like projections extending into the fatty tissue near the renal vein—the physicians at MUSC in Charleston were understandably concerned about the ability to remove the tumor while preserving enough functioning kidney. I was confronted with a possibility that was frighteningly simple: If my remaining kidney could not be saved, I would have no kidneys. I could require dialysis for the rest of my life. The possibility was considered serious enough that preparations for dialysis were being discussed in the event that too much blood was lost, the kidney could not be preserved, or circumstances during surgery required removal of the remaining kidney. At nearly 69 years old, with significant heart disease and only one kidney, the stakes could hardly have been higher. But my wife refused to accept that we had reached the end of our options. She found Dr. Marc Smaldone at Fox Chase Cancer Center in Philadelphia. We lived approximately 700 miles away, but distance meant nothing to us. If there was a surgeon with the experience, skill and courage to attempt to save my remaining kidney, I was going to find him. My first appointment with Dr. Smaldone was in January 2026. The day before the appointment, his nurse called and asked whether I was actually coming. Dr. Smaldone apparently could not believe that I was really going to drive approximately 700 miles just to see him. I was. During that first appointment, Dr. Smaldone told me that one of the reasons he had agreed to take my case was its unusual nature and everything I had already overcome since 2018. That conversation changed something in me. I knew the risks. I understood my age. I understood my heart disease. I understood that I had only one kidney. And I understood what losing that kidney could mean. But I also knew something else: I had found the surgeon I wanted standing over that operating table. We initially attempted systemic cancer therapy for approximately
Marc C. Smaldone holds an active medical license in the state of Pennsylvania.
Medical Doctor with an active medical license in the state of Pennsylvania that expires in 2026.
Completed their residency at University Of Pittsburgh Medical Center.
Graduated from Renaissance School Of Medicine At Stony Brook University in 2004.
Marc C. Smaldone's NPI number is 1225292477.
Our provider data is gathered directly from physicians and publicly available databases. Providers who verify their profiles gain the ability to update information, offering additional details about their specialties,education, treated conditions, performed procedures, and accepted insurances.
Reviews on Vitals are submitted by users only. Recognizing the valuable insights these reviews offer into a doctor's reputation, we maintain internal policies and protocols to ensure the quality and accuracy of all reviews. Importantly, providers cannot delete or alter reviews independently. Reviews can only be deleted or changed following an internal assessment by our customer service team.
Your feedback is highly valued and we encourage you to contact our support team should you encounter any issues.